Global Gene Therapy Supply, Demand and Key Producers, 2024-2030

Description

The global Gene Therapy market size is expected to reach $ 37570 million by 2030, rising at a market growth of 26.4% CAGR during the forecast period (2024-2030).

Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.

In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

This report studies the global Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gene Therapy total market, 2019-2030, (USD Million)
Global Gene Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Gene Therapy total market, key domestic companies and share, (USD Million)
Global Gene Therapy revenue by player and market share 2019-2024, (USD Million)
Global Gene Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Gene Therapy total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gene Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gene Therapy Market, Segmentation by Type
    Viral Gene Therapy
    Non-Viral Gene Therapy

Global Gene Therapy Market, Segmentation by Application
    Neurological Diseases
    Cancer
    Other

Companies Profiled:
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

Key Questions Answered
1. How big is the global Gene Therapy market?
2. What is the demand of the global Gene Therapy market?
3. What is the year over year growth of the global Gene Therapy market?
4. What is the total value of the global Gene Therapy market?
5. Who are the major players in the global Gene Therapy market?

Table of Contents

1 Supply Summary
    1.1 Gene Therapy Introduction
    1.2 World Gene Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Gene Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Gene Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Gene Therapy Market Size (2019-2030)
        1.3.3 China Gene Therapy Market Size (2019-2030)
        1.3.4 Europe Gene Therapy Market Size (2019-2030)
        1.3.5 Japan Gene Therapy Market Size (2019-2030)
        1.3.6 South Korea Gene Therapy Market Size (2019-2030)
        1.3.7 ASEAN Gene Therapy Market Size (2019-2030)
        1.3.8 India Gene Therapy Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gene Therapy Major Market Trends

2 Demand Summary
    2.1 World Gene Therapy Consumption Value (2019-2030)
    2.2 World Gene Therapy Consumption Value by Region
        2.2.1 World Gene Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Gene Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Gene Therapy Consumption Value (2019-2030)
    2.4 China Gene Therapy Consumption Value (2019-2030)
    2.5 Europe Gene Therapy Consumption Value (2019-2030)
    2.6 Japan Gene Therapy Consumption Value (2019-2030)
    2.7 South Korea Gene Therapy Consumption Value (2019-2030)
    2.8 ASEAN Gene Therapy Consumption Value (2019-2030)
    2.9 India Gene Therapy Consumption Value (2019-2030)

3 World Gene Therapy Companies Competitive Analysis
    3.1 World Gene Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Gene Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in 2023
    3.3 Gene Therapy Company Evaluation Quadrant
    3.4 Gene Therapy Market: Overall Company Footprint Analysis
        3.4.1 Gene Therapy Market: Region Footprint
        3.4.2 Gene Therapy Market: Company Product Type Footprint
        3.4.3 Gene Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Gene Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Gene Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Gene Therapy Consumption Value Comparison
        4.2.1 United States VS China: Gene Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Gene Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Gene Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Gene Therapy Revenue, (2019-2024)
    4.4 China Based Companies Gene Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Gene Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Gene Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Gene Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Gene Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Gene Therapy Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Gene Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Viral Gene Therapy
        5.2.2 Non-Viral Gene Therapy
    5.3 Market Segment by Type
        5.3.1 World Gene Therapy Market Size by Type (2019-2024)
        5.3.2 World Gene Therapy Market Size by Type (2025-2030)
        5.3.3 World Gene Therapy Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Gene Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Neurological Diseases
        6.2.2 Cancer
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Gene Therapy Market Size by Application (2019-2024)
        6.3.2 World Gene Therapy Market Size by Application (2025-2030)
        6.3.3 World Gene Therapy Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Biogen
        7.1.1 Biogen Details
        7.1.2 Biogen Major Business
        7.1.3 Biogen Gene Therapy Product and Services
        7.1.4 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Biogen Recent Developments/Updates
        7.1.6 Biogen Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Gene Therapy Product and Services
        7.2.4 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Details
        7.3.2 Gilead Sciences Major Business
        7.3.3 Gilead Sciences Gene Therapy Product and Services
        7.3.4 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Gilead Sciences Recent Developments/Updates
        7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Details
        7.4.2 Sarepta Therapeutics Major Business
        7.4.3 Sarepta Therapeutics Gene Therapy Product and Services
        7.4.4 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Sarepta Therapeutics Recent Developments/Updates
        7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.5 Alnylam Pharmaceuticals
        7.5.1 Alnylam Pharmaceuticals Details
        7.5.2 Alnylam Pharmaceuticals Major Business
        7.5.3 Alnylam Pharmaceuticals Gene Therapy Product and Services
        7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
        7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 Amgen
        7.6.1 Amgen Details
        7.6.2 Amgen Major Business
        7.6.3 Amgen Gene Therapy Product and Services
        7.6.4 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Amgen Recent Developments/Updates
        7.6.6 Amgen Competitive Strengths & Weaknesses
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Details
        7.7.2 Spark Therapeutics Major Business
        7.7.3 Spark Therapeutics Gene Therapy Product and Services
        7.7.4 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Spark Therapeutics Recent Developments/Updates
        7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.8 Akcea Therapeutics
        7.8.1 Akcea Therapeutics Details
        7.8.2 Akcea Therapeutics Major Business
        7.8.3 Akcea Therapeutics Gene Therapy Product and Services
        7.8.4 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Akcea Therapeutics Recent Developments/Updates
        7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
    7.9 bluebird bio
        7.9.1 bluebird bio Details
        7.9.2 bluebird bio Major Business
        7.9.3 bluebird bio Gene Therapy Product and Services
        7.9.4 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 bluebird bio Recent Developments/Updates
        7.9.6 bluebird bio Competitive Strengths & Weaknesses
    7.10 Sunway Biotech
        7.10.1 Sunway Biotech Details
        7.10.2 Sunway Biotech Major Business
        7.10.3 Sunway Biotech Gene Therapy Product and Services
        7.10.4 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Sunway Biotech Recent Developments/Updates
        7.10.6 Sunway Biotech Competitive Strengths & Weaknesses
    7.11 SIBIONO
        7.11.1 SIBIONO Details
        7.11.2 SIBIONO Major Business
        7.11.3 SIBIONO Gene Therapy Product and Services
        7.11.4 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 SIBIONO Recent Developments/Updates
        7.11.6 SIBIONO Competitive Strengths & Weaknesses
    7.12 AnGes
        7.12.1 AnGes Details
        7.12.2 AnGes Major Business
        7.12.3 AnGes Gene Therapy Product and Services
        7.12.4 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 AnGes Recent Developments/Updates
        7.12.6 AnGes Competitive Strengths & Weaknesses
    7.13 Orchard Therapeutics
        7.13.1 Orchard Therapeutics Details
        7.13.2 Orchard Therapeutics Major Business
        7.13.3 Orchard Therapeutics Gene Therapy Product and Services
        7.13.4 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Orchard Therapeutics Recent Developments/Updates
        7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses
    7.14 Human Stem Cells Institute
        7.14.1 Human Stem Cells Institute Details
        7.14.2 Human Stem Cells Institute Major Business
        7.14.3 Human Stem Cells Institute Gene Therapy Product and Services
        7.14.4 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Human Stem Cells Institute Recent Developments/Updates
        7.14.6 Human Stem Cells Institute Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gene Therapy Industry Chain
    8.2 Gene Therapy Upstream Analysis
    8.3 Gene Therapy Midstream Analysis
    8.4 Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gene Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Gene Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Gene Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Gene Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Gene Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Gene Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Gene Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Gene Therapy Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Gene Therapy Players in 2023
    Table 12. World Gene Therapy Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Gene Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Gene Therapy Player
    Table 15. Gene Therapy Market: Company Product Type Footprint
    Table 16. Gene Therapy Market: Company Product Application Footprint
    Table 17. Gene Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Gene Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Gene Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Gene Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Gene Therapy Revenue Market Share (2019-2024)
    Table 23. China Based Gene Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Gene Therapy Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Gene Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Gene Therapy Revenue Market Share (2019-2024)
    Table 29. World Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Gene Therapy Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Gene Therapy Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Gene Therapy Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Gene Therapy Market Size by Application (2025-2030) & (USD Million)
    Table 35. Biogen Basic Information, Area Served and Competitors
    Table 36. Biogen Major Business
    Table 37. Biogen Gene Therapy Product and Services
    Table 38. Biogen Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Biogen Recent Developments/Updates
    Table 40. Biogen Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Gene Therapy Product and Services
    Table 44. Novartis Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Gilead Sciences Basic Information, Area Served and Competitors
    Table 48. Gilead Sciences Major Business
    Table 49. Gilead Sciences Gene Therapy Product and Services
    Table 50. Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Gilead Sciences Recent Developments/Updates
    Table 52. Gilead Sciences Competitive Strengths & Weaknesses
    Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 54. Sarepta Therapeutics Major Business
    Table 55. Sarepta Therapeutics Gene Therapy Product and Services
    Table 56. Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Sarepta Therapeutics Recent Developments/Updates
    Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
    Table 60. Alnylam Pharmaceuticals Major Business
    Table 61. Alnylam Pharmaceuticals Gene Therapy Product and Services
    Table 62. Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
    Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    Table 65. Amgen Basic Information, Area Served and Competitors
    Table 66. Amgen Major Business
    Table 67. Amgen Gene Therapy Product and Services
    Table 68. Amgen Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Amgen Recent Developments/Updates
    Table 70. Amgen Competitive Strengths & Weaknesses
    Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
    Table 72. Spark Therapeutics Major Business
    Table 73. Spark Therapeutics Gene Therapy Product and Services
    Table 74. Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Spark Therapeutics Recent Developments/Updates
    Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 77. Akcea Therapeutics Basic Information, Area Served and Competitors
    Table 78. Akcea Therapeutics Major Business
    Table 79. Akcea Therapeutics Gene Therapy Product and Services
    Table 80. Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Akcea Therapeutics Recent Developments/Updates
    Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
    Table 83. bluebird bio Basic Information, Area Served and Competitors
    Table 84. bluebird bio Major Business
    Table 85. bluebird bio Gene Therapy Product and Services
    Table 86. bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. bluebird bio Recent Developments/Updates
    Table 88. bluebird bio Competitive Strengths & Weaknesses
    Table 89. Sunway Biotech Basic Information, Area Served and Competitors
    Table 90. Sunway Biotech Major Business
    Table 91. Sunway Biotech Gene Therapy Product and Services
    Table 92. Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Sunway Biotech Recent Developments/Updates
    Table 94. Sunway Biotech Competitive Strengths & Weaknesses
    Table 95. SIBIONO Basic Information, Area Served and Competitors
    Table 96. SIBIONO Major Business
    Table 97. SIBIONO Gene Therapy Product and Services
    Table 98. SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. SIBIONO Recent Developments/Updates
    Table 100. SIBIONO Competitive Strengths & Weaknesses
    Table 101. AnGes Basic Information, Area Served and Competitors
    Table 102. AnGes Major Business
    Table 103. AnGes Gene Therapy Product and Services
    Table 104. AnGes Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. AnGes Recent Developments/Updates
    Table 106. AnGes Competitive Strengths & Weaknesses
    Table 107. Orchard Therapeutics Basic Information, Area Served and Competitors
    Table 108. Orchard Therapeutics Major Business
    Table 109. Orchard Therapeutics Gene Therapy Product and Services
    Table 110. Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Orchard Therapeutics Recent Developments/Updates
    Table 112. Human Stem Cells Institute Basic Information, Area Served and Competitors
    Table 113. Human Stem Cells Institute Major Business
    Table 114. Human Stem Cells Institute Gene Therapy Product and Services
    Table 115. Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Gene Therapy Upstream (Raw Materials)
    Table 117. Gene Therapy Typical Customers
List of Figure
    Figure 1. Gene Therapy Picture
    Figure 2. World Gene Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Gene Therapy Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Gene Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Gene Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 13. Gene Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Gene Therapy by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy Markets in 2023
    Figure 27. United States VS China: Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Gene Therapy Market Size Market Share by Type in 2023
    Figure 31. Viral Gene Therapy
    Figure 32. Non-Viral Gene Therapy
    Figure 33. World Gene Therapy Market Size Market Share by Type (2019-2030)
    Figure 34. World Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Gene Therapy Market Size Market Share by Application in 2023
    Figure 36. Neurological Diseases
    Figure 37. Cancer
    Figure 38. Other
    Figure 39. Gene Therapy Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute